GLP-1(7-36) amide vs Atrial Natriuretic Peptide (ANP-28)
Head-to-head comparison of GLP-1(7-36) amide (Glucagon-like peptide-1 (7-36) amide) and Atrial Natriuretic Peptide (ANP-28) (Human Atrial Natriuretic Peptide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | GLP-1(7-36) amide | Atrial Natriuretic Peptide (ANP-28) |
|---|---|---|
| Category | Endocrine Peptides | Endocrine Peptides |
| Full Name | Glucagon-like peptide-1 (7-36) amide | Human Atrial Natriuretic Peptide |
| Molecular Weight | 3297.7 Da | ~3070 Da |
| Half-Life | 1-2 min | 2-5 min |
| Amino Acids | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | SLRRSSCFGGRMDRIGAQSGLGCNSFRY |
| Typical Dose | pM-nM physiologic range|research-dependent | N/A |
| Route | endogenous secretion|SC/IV in research/clinical analog studies | IV infusion |
| Purity | ≥98% | ≥98% |
| Studies Count | 99 | 85 |
| Research Status | Endogenous | Endogenous |
GLP-1(7-36) amide Benefits
- ✓glucose-dependent insulin secretion
- ✓gastric emptying delay
- ✓satiety signaling
Atrial Natriuretic Peptide (ANP-28) Benefits
- ✓natriuresis
- ✓vasodilation
- ✓cGMP elevation
GLP-1(7-36) amide Dosing
physiologic secretion|research-dependent
Atrial Natriuretic Peptide (ANP-28) Dosing
N/A|N/A
GLP-1(7-36) amide Side Effects
- ⚠nausea
- ⚠fullness
- ⚠reduced appetite
Atrial Natriuretic Peptide (ANP-28) Side Effects
- ⚠hypotension
- ⚠dizziness
Research Overview
GLP-1(7-36) amide
One of the best-studied gut hormones, with strong evidence for incretin biology and appetite regulation. Native GLP-1 is rapidly degraded by DPP-4, which is why its biology is central to endocrine and metabolic pharmacology.
Atrial Natriuretic Peptide (ANP-28)
Well-documented endogenous hormone central to blood-pressure and volume regulation; extensively studied as a biomarker and as a mechanistic probe for cGMP signaling.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.